Table 3

Process measure improvement per hospital temporally associated with participation in the EPOCH trial QI programme

Care processesData signals (shifts and runs) identified on run chart analysis
Number (%) of hospitals with care process improvement
observed
n=80
Number (%) of hospitals with median baseline care process delivery ≥80%
n=80
Number (%) of hospitals with degraded care-process after activation to EPOCH
n=80
% Difference post intervention vs pre intervention (median, IQR, range)
1. Consultant led decision making14 (17.5)71 (88.8)6 (7.5)0.44
(2.53–3.35, −16.19 to 20.33)
2. Consultant review of patient before surgery17 (21.25)14 (17.5)4 (5)2.4109
(−3.67 to 6.37, −18.19 to 17.73)
3. Preoperative risk assessment documented57 (71.25)6 (7.5)3 (3.8)13.66
(3.25–23.48, −21.75 to 52.15)
4. Time from decision to operate to entrance to the operating theatre14 (17.5)2 (2.5)5 (6.3) Time in hours
−0.500
(−1.30 to 0.37, −8.25 to 3.4083)
5. Time to theatre within NCEPOD timeframe22 (27.5)32 (40)2 (2.5)8.391
(1.65–12.18, −7.81 to 25.65)
6. Consultant delivered surgery24 (30.0)70 (87.5)2 (2.5)1.913
(−1.96 to 6.52, −13.86 to 18.66)
7. Consultant delivered anaesthesia29 (36.25)57 (71.3)4 (5)3.8416
(−0.74 to 8.68, −22.948 to 30.30)
8. Cardiac output monitoring to guide fluid therapy32 (40.0)3 (3.8)11 (13.8)4.766
(−1.10 to 13.25, −29.21 to 50.72)
9. Measurement of serum lactate intraoperatively42 (52.5)3 (3.8)3 (3.8)9.270
(2.14–17.52, −28.09 to 39.86)
10. Admission to critical care postoperatively28 (35.0)15 (18.8)3 (3.8)2.222
(−3.62 to 7.33, −17.69 to 26.88)
  • EPOCH, Enhanced Peri-Operative Care for High-risk patients .